SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

WEEDCOIN is trending amidst community discussions surrounding the potential rescheduling of cannabis and upcoming policy deadlines for hemp products, with enthusiasts highlighting its role as a culture-first cryptocurrency on Solana ahead of the 4/20 period. The narrative emphasizes its alignment with the broader cannabis movement and a long-term, patient investment approach.

SSgA Active Trust - State Street Technology Select Sector SPDR ETF

Technology Select Sector SPDR Fund

XLK is drawing investor attention amid a noticeable sector rotation away from technology and into areas like energy and defensive stocks. This shift is amplified by varied earnings reports from major tech components and ongoing concerns within the community about the sustainability of AI-driven growth and high capital expenditures.

SSgA Active Trust - State Street Materials Select Sector SPDR ETF

Materials Select Sector SPDR Fund

Materials Select Sector SPDR Fund (XLB) is gaining significant attention following recent tariff announcements on key minerals like copper and Chinese graphite, which are seen as inflationary catalysts boosting domestic production. The community is actively discussing a broader market rotation into materials as an undervalued cyclical sector and inflation hedge, with many anticipating further upside despite some calls for consolidation.

SSgA Active Trust - State Street Industrial Select Sector SPDR ETF

Industrial Select Sector SPDR Fund

The Industrial Select Sector SPDR Fund (XLI) is trending as the community highlights its strong technical structure and leadership amid broader market rotation, fueled by impressive industrial earnings and a positive outlook for manufacturing activity.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is drawing significant community discussion propelled by high-visibility marketing on the Las Vegas Sphere and new partnerships with brands like the NHL, fueling anticipation for its expanding real-world utility amid fluctuating meme coin sentiment.

iShares Trust - iShares 0-3 Month Treasury Bond ETF

iShares 0-3 Month Treasury Bond ETF

Investors are increasingly turning to SGOV, the iShares 0-3 Month Treasury Bond ETF, as a secure 'cash parking' strategy amid broader market uncertainty and anticipation of a potential pullback. The community is actively touting its attractive 4-5% monthly yield and state tax exemption as a preferred low-risk alternative to traditional savings accounts and higher-volatility assets.

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner in 2017 and is headquartered in Dallas, TX.

Forte Biosciences Inc

Forte Biosciences is trending following an oversubscribed $53 million private placement from leading healthcare institutional investors, coupled with promising Phase 1b trial data for its FB102 candidate in celiac disease. The community is actively debating the stock's potential for a significant rally due to the low float and strong institutional backing, amidst discussions of past volatility and potential dilution.

Direxion Shares ETF Trust - Direxion Daily GOOGL Bull 2X Shares

Direxion Daily GOOGL Bull 2X Shares ETF

GGLL is surging as the community aggressively leverages bullish sentiment around Alphabet's significant AI advancements, including Gemini's growing market share and the strategic adoption of its efficient TPU chips. Many see Google as poised to lead mega-cap tech, driving active dip-buying and high conviction in its continued ascent.

Ventyx Biosciences, Inc. engages in developing novel small molecule therapeutics for the treatment of autoimmune diseases. Its clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1-ready peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions. The company was founded by Raju S. Mohan on November 21, 2018 and is headquartered in San Diego, CA.

Ventyx Biosciences Inc

Ventyx Biosciences is trending significantly due to reports that Eli Lilly is nearing a $1 billion acquisition, which many in the community consider a lowball offer for its innovative pipeline. This potential deal has sparked intense speculation about a bidding war, as other major pharmaceutical players are eager to secure Ventyx's leading NLRP3 inhibitor assets and their synergistic potential with GLP-1 therapies in the burgeoning inflammation and cardiometabolic markets.

Invesco Capital Management LLC - Invesco High Yield Equity Dividend Achievers ETF

Invesco High Yield Equity Dividend Achievers ETF

The Invesco High Yield Equity Dividend Achievers ETF ($PEY) is gaining significant community attention as investors actively compare its attractive yield and tax efficiency against other dividend funds like $SCHD. This interest is amplified by a broader market shift towards dividend stocks and is supported by a notable decrease in short interest and favorable analyst sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$GME For those who have shares with a high cost basis left, I tried to simplify my decision process and consider tax loss harvesting also, does it make sense to sell a covered call on shares remaining?  We can try to use excel to answer this. Further details in replies

In short, there&#39;s an inflection point where selling uncovered shares will bring more value, but that point may be higher than you think once you account for tax loss harvesting.  Below is a scenario where one owns 100 shares @ a $250 cost basis and is considering selling a $260 strike CC expiring in November.

You must sell your CC OTM, please consult a tax professional - this is not financial advice. This doesn&#39;t account for calls being exercised early, and it also assumes no wash sales.

This will not be 100% accurate and if you find a major error let me know.  This was only an exercise to help me make quicker decisions.

Oscar Marcil

Allison

Sun. Fly.

All People Equal

harry ham

StockTwits Web

GameStop Corp

 For those who have shares with a high cost basis left, I tried to simplify my decision process and consider tax loss harvesting also, does it make sense to sell a covered call on shares remaining?  We can try to use excel to answer this. Further details in replies

In short, there's an inflection point where selling uncovered shares will bring more value, but that point may be higher than you think once you account for tax loss harvesting.  Below is a scenario where one owns 100 shares @ a $250 cost basis and is considering selling a $260 strike CC expiring in November.

You must sell your CC OTM, please consult a tax professional - this is not financial advice. This doesn't account for calls being exercised early, and it also assumes no wash sales.

This will not be 100% accurate and if you find a major error let me know.  This was only an exercise to help me make quicker decisions.

Block Inc

Slanted Angles

 Here is the set-up for the excel.  The columns highlighted in beige are manual inputs.  For the formulas just do the first cell and double click the bottom right edge of the cell to auto populate it.

 What&#39;s the takeaway here for me personally? Since the inflection point is right around $418, GME would have to go above that to make it worth it for me to sell the shares.  What&#39;s the probability of that happening? Who knows but if I wanted to I could say okay if I don&#39;t have more than 50% confidence it will go over that inflection point, maybe I&#39;ll sell CC on 60-80% of my position and then let the rest ride. 
The key takeaway, is that I can make this decision quicker knowing at what price/premium/tax harvesting combination will give me the most value.

 What's the takeaway here for me personally? Since the inflection point is right around $418, GME would have to go above that to make it worth it for me to sell the shares.  What's the probability of that happening? Who knows but if I wanted to I could say okay if I don't have more than 50% confidence it will go over that inflection point, maybe I'll sell CC on 60-80% of my position and then let the rest ride. 
The key takeaway, is that I can make this decision quicker knowing at what price/premium/tax harvesting combination will give me the most value.